Neuromuscular Diseases
"Neuromuscular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
Descriptor ID |
D009468
|
MeSH Number(s) |
C10.668
|
Concept/Terms |
Foley-Denny-Brown Syndrome- Foley-Denny-Brown Syndrome
- Foley Denny Brown Syndrome
- Syndrome, Foley-Denny-Brown
- Fasciculation-Cramp Syndrome, Benign
- Benign Fasciculation-Cramp Syndrome
- Benign Fasciculation-Cramp Syndromes
- Fasciculation Cramp Syndrome, Benign
- Fasciculation-Cramp Syndromes, Benign
- Cramp-Fasciculation Syndrome
- Cramp Fasciculation Syndrome
- Cramp-Fasciculation Syndromes
- Syndrome, Cramp-Fasciculation
- Syndromes, Cramp-Fasciculation
Oppenheim Disease- Oppenheim Disease
- Oppenheim's Disease
- Oppenheims Disease
- Amyotonia Congenita
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Diseases".
This graph shows the total number of publications written about "Neuromuscular Diseases" by people in this website by year, and whether "Neuromuscular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 | 1994 | 2 | 0 | 2 | 1995 | 1 | 0 | 1 | 1997 | 1 | 0 | 1 | 2000 | 0 | 1 | 1 | 2003 | 0 | 1 | 1 | 2004 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 2012 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2014 | 0 | 1 | 1 | 2015 | 0 | 1 | 1 | 2016 | 1 | 1 | 2 | 2017 | 2 | 0 | 2 | 2018 | 7 | 0 | 7 | 2019 | 1 | 1 | 2 | 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Neuromuscular Diseases" by people in Profiles.
-
Yea C, Bitnun A, Branson HM, Ciftci-Kavaklioglu B, Rafay MF, Fortin O, Moresoli P, Sébire G, Srour M, Decaluwe H, Marois L, Pelletier F, Barton M, Nouri MN, Brophy J, Venkateswaran S, Pohl D, Selby K, Jones K, Robinson J, Mineyko A, Licht C, Ertl-Wagner B, Yeh EA. Association of outcomes in acute flaccid myelitis with identification of enterovirus at presentation: a Canadian, nationwide, longitudinal study. Lancet Child Adolesc Health. 2020 11; 4(11):828-836.
-
van Putten M, Hmeljak J, Aartsma-Rus A, Dowling JJ. Moving neuromuscular disorders research forward: from novel models to clinical studies. Dis Model Mech. 2020 02 25; 13(2).
-
Zhao M, Smith L, Volpatti J, Fabian L, Dowling JJ. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish. Hum Mol Genet. 2019 12 15; 28(24):4186-4196.
-
Rose L, McKim D, Leasa D, Nonoyama M, Tandon A, Bai YQ, Amin R, Katz S, Goldstein R, Gershon A. Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014). PLoS One. 2019; 14(3):e0210574.
-
Fishman H, Massicotte C, Li R, Zabih W, McAdam LC, Al-Saleh S, Amin R. The Accuracy of an Ambulatory Level III Sleep Study Compared to a Level I Sleep Study for the Diagnosis of Sleep-Disordered Breathing in Children With Neuromuscular Disease. J Clin Sleep Med. 2018 12 15; 14(12):2013-2020.
-
Gill PJ, Bitnun A, Yeh EA. Acute flaccid myelitis. CMAJ. 2018 12 03; 190(48):E1418.
-
Ertl-Wagner B, Branson H, Shroff M, Bitnun A, Yeh EA. Acute Flaccid Myelitis in a 10-Year-Old Girl. Radiology. 2019 01; 290(1):31.
-
Zhao M, Maani N, Dowling JJ. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease. Neurotherapeutics. 2018 10; 15(4):966-975.
-
Rose L, McKim D, Leasa D, Nonoyama M, Tandon A, Bai YQ, Amin R, Katz S, Goldstein R, Gershon A. Patterns of healthcare utilisation for respiratory complications of adults with neuromuscular disease: a population study. Eur Respir J. 2018 09; 52(3).
-
Rose L, McKim D, Leasa D, Nonoyama M, Tandon A, Kaminska M, O'Connell C, Loewen A, Connolly B, Murphy P, Hart N, Road J. Monitoring Cough Effectiveness and Use of Airway Clearance Strategies: A Canadian and UK Survey. Respir Care. 2018 Dec; 63(12):1506-1513.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|